title: Three human cell types respond to multi-walled carbon nanotubes and titanium dioxide nanobelts with cell-specific transcriptomic and proteomic expression patterns.
abstract: The growing use of engineered nanoparticles (NPs) in commercial and medical applications raises the urgent need for tools that can predict NP toxicity. Global transcriptome and proteome analyses were conducted on three human cell types, exposed to two high aspect ratio NP types, to identify patterns of expression that might indicate high versus low NP toxicity. Three cell types representing the most common routes of human exposure to NPs, including macrophage-like (THP-1), small airway epithelial and intestinal (Caco-2/HT29-MTX) cells, were exposed to TiO2 nanobelts (TiO2-NB; high toxicity) and multi-walled carbon nanotubes (MWCNT; low toxicity) at low (10 µg/mL) and high (100 µg/mL) concentrations for 1 and 24 h. Unique patterns of gene and protein expressions were identified for each cell type, with no differentially expressed (p < 0.05, 1.5-fold change) genes or proteins overlapping across all three cell types. While unique to each cell type, the early response was primarily independent of NP type, showing similar expression patterns in response to both TiO2-NB and MWCNT. The early response might, therefore, indicate a general response to insult. In contrast, the 24 h response was unique to each NP type. The most significantly (p < 0.05) enriched biological processes in THP-1 cells indicated TiO2-NB regulation of pathways associated with inflammation, apoptosis, cell cycle arrest, DNA replication stress and genomic instability, while MWCNT-regulated pathways indicated increased cell proliferation, DNA repair and anti-apoptosis. These two distinct sets of biological pathways might, therefore, underlie cellular responses to high and low NP toxicity, respectively.
authors: Environmental Molecular Sciences Laboratory, and Fundamental & Computational Sciences Directorate, Pacific Northwest National Laboratory , Richland, WA , USA.
authors: Susan C
authors: SC
authors: Tilton
authors: Norman J
authors: NJ
authors: Karin
authors: Ana
authors: A
authors: Tolic
authors: Yumei
authors: Y
authors: Xie
authors: Xianyin
authors: X
authors: Lai
authors: Raymond F
authors: RF
authors: Hamilton
authors: Katrina M
authors: KM
authors: Waters
authors: Andrij
authors: A
authors: Holian
authors: Frank A
authors: FA
authors: Witzmann
authors: Galya
authors: G
authors: Orr
mesh_terms: D018938:Caco-2 Cells; D002470:Cell Survival / Q000187:drug effects; D016000:Cluster Analysis; D053263:Gene Regulatory Networks / Q000187:drug effects; D019073:HT29 Cells; D006801:Humans; D037742:Nanotubes, Carbon / Q000737:chemistry / Q000633:toxicity*; D020543:Proteome / Q000032:analysis / Q000737:chemistry / Q000187:drug effects*; D014025:Titanium / Q000737:chemistry / Q000633:toxicity*; D059467:Transcriptome / Q000187:drug effects*
chemical_list: D037742:Nanotubes, Carbon; D020543:Proteome; C009495:titanium dioxide; D014025:Titanium
references: Int J Environ Res Public Health. 2005 Apr;2(1):31-42
references: 16705799
references: Part Fibre Toxicol. 2009 Dec 31;6:35
references: 20043844
references: J Toxicol Environ Health A. 2002 Aug 9;65(15):1047-60
references: 12167218
references: PLoS One. 2012;7(4):e34977
references: 22529966
references: Eur Rev Med Pharmacol Sci. 2011 May;15(5):481-508
references: 21744743
references: ACS Nano. 2009 Aug 25;3(8):2274-80
references: 19610603
references: Acta Biomater. 2007 May;3(3):351-8
references: 17275430
references: Environ Mol Mutagen. 2008 Jun;49(5):399-405
references: 18418868
references: J Nutr Biochem. 2009 Jul;20(7):494-502
references: 18715773
references: Bioinformatics. 2003 Jan 22;19(2):185-93
references: 12538238
references: Toxicol Lett. 2007 Jan 10;168(1):58-74
references: 17141434
references: J Pharm Sci. 1996 Oct;85(10):1070-6
references: 8897273
references: Trends Cell Biol. 2002 Nov;12(11):509-16
references: 12446112
references: Drug Metab Dispos. 2012 Mar;40(3):579-87
references: 22187486
references: Environ Health Perspect. 2007 Aug;115(8):1125-31
references: 17687437
references: Toxicol Lett. 2010 Aug 1;197(1):29-37
references: 20435104
references: Part Fibre Toxicol. 2005 Oct 06;2:8
references: 16209704
references: Environ Sci Technol. 2005 Mar 1;39(5):1378-83
references: 15787380
references: Toxicol Sci. 2006 May;91(1):227-36
references: 16495353
references: Cancer Res. 2009 Nov 15;69(22):8784-9
references: 19887611
references: Part Fibre Toxicol. 2010 Oct 04;7:28
references: 20920331
references: Surf Interface Anal. 2012 Aug;44(5):882-889
references: 23430137
references: J Toxicol Environ Health A. 2010;73(5):378-95
references: 20155580
references: Anal Chem. 2002 Oct 15;74(20):5383-92
references: 12403597
references: Toxicol Sci. 2012 Feb;125(2):450-61
references: 21964423
references: Immunology. 2009 Jul;127(3):299-311
references: 19538249
references: ACS Nano. 2010 Dec 28;4(12):7241-52
references: 21067152
references: J Proteome Res. 2011 Oct 7;10(10):4799-812
references: 21888428
references: Nanomedicine (Lond). 2011 Jan;6(1):143-56
references: 21182425
references: Biotechniques. 2003 Feb;34(2):374-8
references: 12613259
references: Inhal Toxicol. 2008 Jan;20(1):53-62
references: 18236223
references: Appl Biochem Biotechnol. 2012 Jun;167(4):791-808
references: 22614867
references: J Am Chem Soc. 2009 Sep 2;131(34):12290-7
references: 19705915
references: Pharmacol Ther. 2009 Feb;121(2):192-204
references: 19103221
references: Toxicol In Vitro. 2009 Dec;23(8):1491-6
references: 19591917
references: Nanotoxicology. 2011 Sep;5(3):354-71
references: 21067278
references: BMC Bioinformatics. 2012 Nov 23;13:311
references: 23174015
references: J Nanosci Nanotechnol. 2008 Nov;8(11):5770-5
references: 19198303
references: Toxicol Lett. 2011 Feb 5;200(3):176-86
references: 21112381
references: Cancer Res. 2000 Jan 1;60(1):184-90
references: 10646872
references: Anal Chem. 2003 Sep 1;75(17):4646-58
references: 14632076
references: Nanotoxicology. 2011 Sep;5(3):341-53
references: 21067279